triiodothyronine has been researched along with fm19g11 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, LA; Duan, M; Gentillon, C; Gibson, GC; Jha, R; Li, D; Preininger, MK; Qu, CK; Rampoldi, A; Saraf, A; Xu, C; Yu, WM | 1 |
1 other study(ies) available for triiodothyronine and fm19g11
| Article | Year |
|---|---|
Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
Topics: Anti-Inflammatory Agents; Benzamides; Calcium; Cell Differentiation; Cells, Cultured; Dexamethasone; Drug Synergism; Energy Metabolism; Fatty Acids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Induced Pluripotent Stem Cells; Insulin-Like Growth Factor I; Lipid Metabolism; Mitochondria; Myocytes, Cardiac; Oxidation-Reduction; PPAR alpha; Transcriptome; Triiodothyronine | 2019 |